Markets

Cardica (CRDC) Jumps: Stock Rises 8.5% - Tale of the Tape

Cardica Inc. ( CRDC ) was a big mover last session, as the company saw its shares rise over 7% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $0.89 to $1.01 in the past one-month time frame.

Though the company has seen no positive revision in the past 30 days, its Zacks Consensus Estimate moved higher over the same time frame, suggesting that more solid trading could be ahead for Cardica. So make sure to keep an eye on this stock going forward to see if yesterday's jump can turn into more strength down the road.

Cardica currently has a Zacks Rank #2 (Buy) while its Earnings ESP is 0.00%.

Other stocks worth considering in the medical products industry include Venaxis, Inc. ( APPY ), ICU Medical, Inc. ( ICUI ) and Eagle Pharmaceuticals Inc. ( EGRX ). All of these have the same Zacks Ranks as Cardica.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days . Click to get this free report >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

CARDICA INC (CRDC): Free Stock Analysis Report

VENAXIS INC (APPY): Get Free Report

ICU MEDICAL INC (ICUI): Free Stock Analysis Report

EAGLE PHARMACT (EGRX): Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

ICUI EGRX

Other Topics

Investing Stocks

Latest Markets Videos

    Zacks

    Zacks is the leading investment research firm focusing on stock research, analysis and recommendations. In 1978, our founder discovered the power of earnings estimate revisions to enable profitable investment decisions. Today, that discovery is still the heart of the Zacks Rank. A wealth of resources for individual investors is available at www.zacks.com.

    Learn More